Bicalutamide
Bicalutamide is a nonsteroidal androgen receptor inhibitor used in defined prostate cancer treatment settings, commonly alongside another form of androgen deprivation.
Key points
- Bicalutamide blocks androgen signalling at its receptor.
- Liver effects and breast tenderness are prominent medicine-specific considerations.
Casodex connects bicalutamide with prostate cancer in oncology support. The treatment setting may include another medicine or intervention, but the attached tablet itself contains bicalutamide alone. This high-risk clinical page requires qualified review.